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Abstract
Background: Pharmacological and gene ablation studies have demonstrated the crucial role of the
endocrine function of the heart as mediated by the polypeptide hormones ANF and BNP in the
maintenance of cardiovascular homeostasis. The importance of these studies lies on the fact that
hypertension and chronic congestive heart failure are clinical entities that may be regarded as states
of relative deficiency of ANF and BNP. These hormones are produced by the atrial muscle cells
(cardiocytes), which display a dual secretory/muscle phenotype. In contrast, ventricular cardiocytes
display mainly a muscle phenotype. Comparatively little information is available regarding the
genetic background for this important phenotypic difference with particular reference to the
endocrine function of the heart. We postulated that comparison of gene expression profiles
between atrial and ventricular muscles would help identify gene transcripts that underlie the
phenotypic differences associated with the endocrine function of the heart.
Results:  Comparison of gene expression profiles in the rat heart revealed a total of 1415
differentially expressed genes between the atria and ventricles based on a 1.8 fold cut-off. The
identification of numerous chamber specific transcripts, such as ANF for the atria and Irx4 for the
ventricles among several others, support the soundness of the GeneChip data and demonstrates
that the differences in gene expression profiles observed between the atrial and ventricular tissues
were not spurious in nature. Pathway analysis revealed unique expression profiles in the atria for
G protein signaling that included Gαo1, Gγ2 and Gγ3, AGS1, RGS2, and RGS6 and the related K+
channels GIRK1 and GIRK4. Transcripts involved in vesicle trafficking, hormone secretion as well
as mechanosensors (e.g. the potassium channel TREK-1) were identified in relationship to the
synthesis, storage and secretion of hormones.
Conclusion: The data developed in this investigation describes for the first time data on gene
expression particularly centred on the secretory function of the heart. This provides for a rational
approach in the investigation of determinants of the endocrine of the heart in health and disease.
Background
In all mammals, atrial cardiac muscle cells (cardiocytes)
display phenotypic differences with their ventricular
counterparts owing to the endocrine function of the
former. Atrial cardiocytes contain secretory-like granules
known as specific atrial granules, which co-store two
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polypeptide hormones, atrial natriuretic factor (ANF or
ANP, Nppa) and B-type natriuretic peptide (BNP, Nppb),
referred to as cardiac natriuretic peptides (NP).
The increase in atrial NP gene expression and secretion
observed during hemodynamic overload is viewed as a
cardioprotective mechanism based on the capacity of ANF
and BNP to reduce load by modulating renal function,
vessel tone, as well as the renin-angiotensin-aldosterone
and the sympathetic nervous systems, among others.
Considerable effort has been focused on the elucidation
of the mechanistic underlying of ANF and BNP gene
expression and secretion by the atrial cardiocytes. The
majority of these investigations have concentrated on
pharmacological interventions but much remains to be
determined regarding specific genes involved in cardio-
cyte secretory function. This information is important
however, to understand why under chronic conditions of
hemodynamic overload such as in chronic congestive
heart failure, the secretion of ANF and BNP is insufficient
as demonstrated by the fact that patients that receive exog-
enous hormone benefit from the unloading of the heart
induced by therapeutic administration of either of the
hormones [1]. Through the present work we have defined
genes that may be fitted within a more detailed view of
cardiac endocrine function.
Results
Differentially expressed genes between atrial and 
ventricular tissues
From the 31042 probe sets found on the microarray, an
average of 59% and 56% of probes had present calls in the
atria and ventricles, respectively. Based on a 1.8 fold
change ratio criterion, 1415 probe sets were statistically
differentially expressed between the atria and ventricles.
Of these, 859 probe sets showed higher expression levels
in the atrial samples and 556 probe sets showed higher
expression levels in the ventricles. The degree of change of
the differentially expressed probes ranged between the 1.8
fold minimum set cut-off and 245 fold (see Additional file
1). Chamber specific genes were found differentially
expressed in our dataset. Sarcolipin, an atrial-specific Ca+2
binding protein was expressed 245.97 fold higher in the
atria than the ventricles. Other atrial specific genes include
dickkopf homolog 3 (DKK3) (3.32 fold), ANF (12.88
fold), and myosin light chain 2a (26.19 fold). In the ven-
tricles, four-and-a-half LIM domain 2 (8.63 fold), myosin
light chain polypeptide 3 (14.78 fold) and Iroquois
homeobox protein 4 (Irx4) (18.44 fold) were identified.
Differential expression of 14 candidate genes was con-
firmed by real time-PCR. The results show excellent agree-
ment between the microarray and PCR data (Figure 1).
Several genes exhibited a higher fold change ratio when
analyzed by PCR as compared to microarray.
Functional classification
Differentially expressed genes between the atria and the
ventricles were functionally classified into four major
Gene Ontology categories: biological process, cellular
component, molecular function and unclassified. An
individual transcript was included in several categories or
subcategories because of its relevance to more than one
category or subcategory. Out of the 1415 significantly dif-
ferentially expressed probes, 837 were grouped as unclas-
sified, i.e. had unknown annotations at the time of the
study. Figure 2 illustrates the extent in gene expression dif-
ferences found between the two heart tissues across func-
tional classes.
Biological processes
Differentially expressed genes were similarly abundant in
cell communication and signal transduction processes
and they were mainly found involved in cell growth,
metabolism, transport, G protein-dependent signaling,
and protein kinase cascade (Figure 2). Differentially
expressed G protein-dependent signaling transcripts
include those grouped in subcategories such as glutamate
signaling, G protein signaling, neuropeptide signaling
pathway, and serotonin receptor signaling (Table 1). Reg-
ulators of G-protein signaling (RGS) RGS2 and RGS6 were
more abundant in the atria (2.61 and 2.47 fold, respec-
tively) while RGS5 was prevalent in the ventricles (2.33
fold) (see Figure 3). Other accessory proteins for G pro-
teins that were found differentially expressed include peri-
plakin (4.23 fold), Rasd1 (also known as Activator of G
protein Signaling 1, AGS1) (3.75 fold) and β-site APP
cleaving enzyme 2 (3.54 fold). These genes were more
abundant in the atria while Rasd2 (3.32 fold) and AGS3-
like (11.43) were more abundant in the ventricles. All
these accessory proteins, including the RGS proteins inter-
act with Gαi/o [2]. Small GTPase-mediated signal trans-
duction transcripts found differentially expressed include
regulators of membrane trafficking including Rab15
(24.53 fold), Rab34 (1.90 fold) and Rab40b (3.27 fold).
The Rab escort protein choroidermia, known to interact
with Rab3a and Rab27a, as well as the Rab27a effector
protein synaptotagmin-like 2 were abundantly expressed
in the atria by 1.86 and 32.25 fold, respectively. The latter
is known to bind and regulate the GTP-bound form of
Ras-related protein Rab27a, which has been shown to
positively regulate the exocytosis of secretory granules in
pancreatic beta cells and pituitary tissue [3].
Genes involved in secretion included signal sequence
receptor gamma (SSR3) (1.82 fold), blocked early in
transport 1 homolog (S. cerevisiae) (Bet1) (1.93 fold),
vesicle trafficking protein like 1 (Sec22) (1.93 fold), syn-
apsin III (1.93 fold) and annexin A1 (2.04 fold). These
genes were found more abundant in the atria when com-
pared to the ventricles.BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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Cellular component
Within the Gene Ontology category of cellular compo-
nents, the intracellular components subcategory con-
tained the largest amount of differentially expressed genes
(n = 156) in comparison to the extracellular (n = 37) and
the membrane components (n = 37). Cellular compo-
nents that had prominent atrial abundant transcripts
included those associated with the plasma membrane, the
endoplasmic reticulum (ER), the Golgi apparatus, and the
nucleus, while the ventricles were associated with abun-
dant transcripts found within the mitochondrion and per-
oxisome components (Figure 2). ER and Golgi-associated
genes that were abundantly expressed in the atria include
stearoyl-CoA desaturase 1 (20.81 fold) and 2 (2.21 fold),
inositol 1,4,5-triphosphate receptor 1 (2.44 fold), ribos-
ome associated membrane protein 4 (2.22 fold), Sec11
like 3 (2.05 fold), as well as SSR3. Transcripts involved in
ER to Golgi vesicle-mediated transport include the previ-
ously mentioned genes Sec22 and Bet1. Other atrial abun-
dant Golgi resident proteins include islet cell autoantigen
of 1 (Ica1) (4.63 fold), transforming growth factor-β2
(TGFβ2) (3.89 fold), nucleobindin 2 (2.35 fold) and
Golgi transport 1 homolog B (Golt1b) (2.60 fold).
Molecular function
The molecular function subcategories that were most
notably differentially expressed between atrial and ven-
tricular muscles included enzyme, signal transducer,
structural protein, and transport (see Figure 2). The signal
transducer subcategory is composed of ligands and recep-
tors (see Additional file 2 and Additional file 3 for com-
plete list of genes). The cytokines, frizzled receptor
ligands, growth factor receptor ligands as well as hormone
receptor ligands subcategories were also significantly dif-
ferentiated. Differentially expressed genes involved in
hormone, hormonal activity, and hormone receptor lig-
and subcategories, including ANF (12.88 fold) and BNP
(1.89 fold), as well as secretory granule neuroendocrine
Comparison of microarray and real-time PCR results Figure 1
Comparison of microarray and real-time PCR results. Relative fold change of 14 candidate genes are shown. The 
results demonstrate agreement between the microarray and RT-PCR data, although the degree of fold change can vary.
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protein 1 (SGNE1) (3.20 fold) are listed in Table 2. Pre-
liminary immunohistochemistry analysis localized
SGNE1 in structures compatible with adrenergic varicosi-
ties (Figure 4). Differentially expressed transcription fac-
tors/DNA binding proteins were more abundant in the
atria than in the ventricles (see Additional file 4 for com-
plete list).
In general, genes coding for transport proteins were more
abundant in the atria than in the ventricles. Potassium
channels, which were most abundant in the atria included
potassium channel subfamily K member 2 (Kcnk2 or
TREK-1), as well as potassium inwardly-rectifying chan-
nel, subfamily J, member 3 (Kcnj3) and 5 (Kcnj5) (Table
3). The ventricles were most abundant in the potassium
inwardly-rectifying channel, subfamily J, member 8
(Kcnj8 also known as Kir6.1) channel subunit.
Pathway analysis
Pathway analysis using the Gene Map Annotator and
Pathway Profiler (GenMapp) software identified clusters
of differentially expressed genes found within the same
biological pathway. Visual representation of specific
known pathways, referred as Mapps, revealed several
Mapps in which atrial gene expression was predominant.
These Mapps included pathways of fatty acid synthesis,
prostaglandin synthesis, as well as eicosanoid synthesis,
which shows a higher abundance of phospholipase A2
(PLA2) (3.28 fold), COX1 (2.11 fold) and COX2 (1.96
fold). In contrast, mitochondrial long-chain fatty acid β-
oxidation and glucocorticoid metabolism pathways were
dominant in ventricular samples. Mapps other than those
from metabolic processes, revealed atrial regional special-
ization in regards to the classical component activation
pathway and G-protein signaling pathway (Figure 5). The
Functional classification of differentially expressed genes found between the atria and the ventricles with known Gene Ontol- ogy annotations Figure 2
Functional classification of differentially expressed genes found between the atria and the ventricles with 
known Gene Ontology annotations. Note that the number of differentially expressed genes are plotted according to mus-
cle type, i.e. atrium or ventricle.
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Normalized intensity values of specific transcripts in all atrial and ventricular microarray replicates Figure 3
Normalized intensity values of specific transcripts in all atrial and ventricular microarray replicates. The data is 
displayed in four different panels for visual simplicity. Note that atrial and ventricular microarrays are labelled as LA(n) and 
LV(n), and the scale of the ordinate axis is different for the upper panel due to high signal intensity values for ANF and BNP. 
Also note that RGS5 and Kcnj3 are represented by two distinct probe sets.
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Table 1: List of differentially expressed genes classified into G protein dependent signaling and related functional groups
Functional Group/Probe set ID Gene Description Fold change
G Protein signaling
1369740_at Potassium inwardly-rectifying channel, subfamily J, member 3 7.76
1368560_at Potassium inwardly-rectifying channel, subfamily J, member 5 7.68
1369741_at Potassium inwardly-rectifying channel, subfamily J, member 3 6.35
1369273_a_at Natriuretic peptide receptor 3 6.02
1396249_at Natriuretic peptide receptor 3 4.06
1387803_at Protein phosphatase 2, regulatory subunit B, beta isoform 3.94
1367920_at Endothelial differentiation, sphingolipid G-protein-coupled receptor, 5 3.27
1367791_at Receptor (calcitonin) activity modifying protein 1 3.05
1392905_at Guanine nucleotide binding protein, gamma 2 2.74
1368879_a_at Guanine nucleotide binding protein, alpha o 2.31
1369377_at Hypocretin receptor 2 2.00
1373202_at Guanine nucleotide binding protein, gamma 3 1.96
1369647_at Calcitonin receptor-like -1.82
1369115_at Adrenergic receptor, beta 2 -1.83
1368660_at cAMP-regulated guanine nucleotide exchange factor I -1.93
1388109_at G protein-coupled hepta-helical receptor Ig-Hepta -1.95
1370449_at G protein-coupled receptor 105 -2.20
1368534_at Adrenergic receptor, alpha 1d -2.34
1398530_at guanine nucleotide binding protein (G protein), gamma 11 -2.34
1368300_at Adenosine A2a receptor -2.46
1370522_at Glucagon receptor -3.07
1395473_at Guanine nucleotide binding protein, beta 3 -3.65
1387671_at Secretin receptor -4.31
Accessory proteins for G proteins
1391187_at Periplakin (predicted) 4.23
1387908_at RAS, dexamethasone-induced 1 (Rasd1/AGS1) 3.75
1377390_at Beta-site APP-cleaving enzyme 2 3.54
1387074_at Regulator of G-protein signaling 2 2.61
1379517_at Regulator of G-protein signaling 6 2.47
1369957_at Regulator of G-protein signaling 5 -2.33
1370372_at RASD family, member 2 -3.32
1372383_at G-protein signaling modulator 1 (AGS3-like, C. elegans) -11.43
Neuropeptide signaling pathway
1367992_at Secretory granule neuroendocrine protein 1 3.20
1382967_at G protein-coupled receptor 64 2.50
1369377_at Hypocretin receptor 2 2.00
1368428_at X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound -1.99
1371696_at G protein-coupled receptor 56 -2.16
1367949_at Preproenkephalin -13.55
Serotonin receptor signaling
1369125_at 5-hydroxytryptamine (serotonin) receptor 2A 7.84
1369124_at 5-hydroxytryptamine (serotonin) receptor 2A 1.88
Positive fold change values indicate a higher abundance in the atria as compared to the ventricles, while negative fold change values demonstrate a 
higher ventricular abundance in comparison to the atria.BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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latter demonstrated a higher abundance of the Gαo1 sub-
unit (Gnao), Kcnj3 and Kcnj5 in the atrium compared to
the ventricle by 2.3, 6.35 (second probe set = 7.76 fold)
and 7.68 fold, respectively. Also, Gγ2 (Gng2), Gγ3 (Gng3)
(2.74 and 1.96 fold, respectively) and phosphodiesterase
7a (Pde7a) (7.52 fold) as well as inositol 1,4,5-triphos-
phate receptor 1 (Itpr1) (2.44 fold) were highly expressed
in the atria while protein kinase C epsilon (Prkcε) was
more abundant in the ventricles by 2.09 fold. Gβ subunits
1, 2, and 5 were present in both atria and ventricles at
roughly similar levels while Gβ3 (Gnb3) was expressed at
higher levels in the ventricles (3.66 fold).
Discussion
Mammalian atrial and ventricular cardiocytes display
striking differences in phenotype. The bulk of atrial cardi-
ocytes have, in addition to features commonly associated
with striated cardiac muscle cell cytology, organelles that
are normally found in cells engaged in the synthesis, vec-
torial transport and secretion of polypeptide hormones.
These include an abundance of rough endoplasmic retic-
ulum, a highly developed Golgi complex and storage
granules containing hormonal products. These cytological
features led to a series of past investigations that culmi-
nated in the discovery of the endocrine function of the
heart [4], which is largely mediated by the polypeptide
hormones ANF and BNP.
From the data presented here it is evident that the pheno-
typic differences between the atria and the ventricles
results from underlying differences in degree or presence/
absence of several specific genes. Despite this complex
background of differential expression, the microarray data
reproducibility observed in different biological replicates
was excellent.
The proportion of probes that were called present, as well
as the number of differentially expressed genes was higher
in the atria than in the ventricles. This observation could
be related to a higher functional complexity of the atrial
tissue, which include contraction, excitation, conduction,
secretion and the presence of a profuse innervation [5,6].
The detection of numerous known chamber specific tran-
scripts [6-9] supports the robustness of the GeneChip data
and demonstrates that the differences in gene expression
profiles observed between the atrial and ventricular tis-
sues are not spurious in nature. A comparative analysis of
the differentially expressed genes identified in other stud-
ies that are in common with our data is presented in the
Additional file 5. Several genes identified in these studies
by others are in agreement with our data, even though
there are experimental differences (such as species, gender
and tissue selection) as well as data analysis between stud-
ies. However, none of these previous studies focused spe-
cifically on gene expression profiles relating to the
endocrine function of the heart.
Based on atrial and ventricular phenotypical differences,
the strategy used in the data mining process was to iden-
tify genes that had Gene Ontology annotations relating to
hormone secretion, hormone activity, vesicle/granule
packaging and transport. Screening for Gene Ontology
terms classified as Golgi apparatus and ER cellular compo-
nents was also undertaken in an effort to identify genes
involved in the regulation of NP packaging and secretion.
Differentially expressed transcription factors as well as
transcripts coding for proteins involved in signal trans-
duction such as ligands and receptors were also of great
interest. Finally, hormone secretion can be modulated/
regulated by ion channels and mechanosensors, hence
genes coding for transport proteins were also of interest.
Differentially expressed genes coding for proteins
involved in metabolic processes as well as contractile pro-
teins were not specifically looked at since these differences
are expected to be found between the atrial and ventricu-
lar tissues but are not thought to be involved in the endo-
crine function of the heart. In general, functional
classification of the differentially expressed genes accord-
ing to their cellular components, identified in our study,
parallels the results obtained by Barth et al.,[5], which
include ventricular abundance of mitochondrial genes as
well as the identification of numerous atrial abundant ER
and Golgi apparatus transcripts, such as Sec22 and Rab34.
The larger number of probes hybridizing to cellular com-
ponents involved in secretory function agrees with the
Paraffin-embedded, paraformaldehyde-fixed atrial tissue sec- tion stained with SGNE1-FITC antibody showing punctuated  fluorescence structures suggesting adrenergic varicosities  (white arrows) Figure 4
Paraffin-embedded, paraformaldehyde-fixed atrial 
tissue section stained with SGNE1-FITC antibody 
showing punctuated fluorescence structures suggest-
ing adrenergic varicosities (white arrows).
BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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phenotypic and functional differences between atrial and
ventricular muscle. For example, atrial cardiocytes were
more abundant in the transcripts coding for ANF and BNP
than the ventricles. Correspondingly, ANF transcript
abundance, which constitutes one to three percent of total
atrial mRNA [10] was found to provide for the top one
percent of the GeneChip® signal intensities. Saturation of
the fluorescent signal is thought to have occurred for ANF
probe sets, which explains the plateau level of 12 fold dif-
ference between atrial vs. ventricular tissues as compared
to 163 fold with RT-PCR (Figure 1). Oligonucleotide
probe saturation can occur when the labeled cRNA is at
high enough levels to result in an almost 100% probe/
cRNA hybridization complex. Any other increase in
expression would not be measurable due to the olignucle-
otide hybridization saturation. It is difficult to estimate
the amount of cRNA needed to saturate the oligonulce-
otide probes since the specific number of oligonucleotide
probes tiled onto the 112 micron surface area of the Gene-
Chip® is proprietary information.
Storage granule-associated proteins identified in this
study include Ica1 [11] and SGNE1. The evolutionary con-
served gene Ica1, was shown to be abundant in human
pancreas and heart, and moderately expressed in brain
[12]. Variable expression of 5'-untranslated region exons
from the Ica1 gene was shown to be tissue specific, where
cardiac tissue distinctively expressed the exon B2 tran-
script variant [13]. The original observation that Ica1
expression levels were high in the heart but null in skeletal
muscle lead Pietropaolo et al., [12] to postulate that Ica1
was present in selective cells. We demonstrate here that
Ica1 is expressed specifically in the atria given that all four
ventricular replicates exhibited an absent detection call for
this transcript (an absent call indicates that the microarray
Table 2: List of differentially expressed genes possessing hormone, hormonal activity, or hormone receptor ligand Gene Ontology 
annotations
Probe Set ID Gene Description Fold change
1367564_at Natriuretic peptide precursor type A (ANF) 12.88
1367616_at Natriuretic peptide precursor type B (BNP) 1.89
1371400_at Thyroid hormone responsive protein 38.59
1387396_at Hepcidin antimicrobial peptide 11.24
1369484_at WNT1 inducible signaling pathway protein 2 4.79
1387625_at Insulin-like growth factor binding protein 6 3.61
1368883_at Top of Form Nephroblastoma overexpressed gene Bottom of Form 3.51
1367992_at Secretory granule neuroendocrine protein 1 (SGNE1) 3.20
1368367_at CUB and zona pellucida-like domains 1 3,17
1368367_at Integral membrane-associated protein 1 3.16
1376734_at Nephroblastoma overexpressed gene 2.79
1372168_s_at Insulin-like growth factor binding protein 6 2.25
1367631_at Connective tissue growth factor 2.20
1389651_at Apelin, AGTRL1 ligand 2.00
1387219_at Adrenomedullin 1.87
1367894_at Growth response protein (CL-6) 1.82
1370563_at 3-alpha-hydroxysteroid dehydrogenase -1.92
1368428_at X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound -1.99
1396101_at Stanniocalcin 1 -2.14
1368468_at Cytochrome P450, subfamily 11A -3.97
1367949_at Preproenkephalin, related sequence -13.55
Positive fold change values indicate a higher abundance in the atria as compared to the ventricles, while negative values demonstrate a higher 
ventricular abundance in comparison to the atria.
Table 3: List of differentially expressed genes encoding for potassium channels
Probe Set ID Gene Description Symbols Fold Change
1369740_at Potassium inwardly-rectifying channel, subfamily J, member 3 Kcnj3 or GIRK1 7.78
1368560_at Potassium inwardly-rectifying channel, subfamily J, member 5 Kcnj5 or GIRK4 7.67
1369741_at Potassium inwardly-rectifying channel, subfamily J, member 3 Kcnj3 or GIRK1 6.36
1370342_at Potassium channel, subfamily K, member 2 Kcnk2 or TREK-1 4.17
1368911_at Potassium inwardly-rectifying channel, subfamily J, member 8 Kcnj8 or Kir6.1 -2.03
Positive fold change values indicate a higher abundance in the atria as compared to the ventricles, while negative values demonstrate a higher 
ventricular abundance in comparison to the atria.BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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expression level for a particular transcript was below the
threshold of detection).
Several studies have been able to co-localize SGNE1, a
member of the secretogranin family, with neuropeptides
and hormones in various tissues that are primarily com-
posed of neuronal or endocrine cells, as well as tissues
known to contain a sub-population of neuroendocrine
cells [14]. RT-PCR analysis further confirmed atrial abun-
dance of SGNE1 (Figure 1). SGNE1 has not been previ-
ously associated with the atria or the heart. Our own
immunofluorescence preliminary data suggest that
SGNE1 protein is localized in structures compatible with
adrenergic varicosities (Figure 4).
Differentially expressed transcription factors/DNA bind-
ing proteins that were more abundant in the atria than in
the ventricles included numerous orphan nuclear recep-
tors. Two out of the three Affymetrix probe sets assaying
for nuclear receptor subfamily 2, group F, member 2
(Nr2f2) transcripts were identified in the atrial abundant
gene list. Nr2f2 expression pattern is in agreement with
previously published data (Additional file 5) and real-
time PCR analysis further validated its atrial abundance
(Figure 1). Other atrial abundant transcription factors
include paired-like homeodomain transcription factor 2
(Pitx2), which is involved in atrial septation; T-box pro-
tein 5 (Tbx5), a known activator of the ANF promoter;
and early growth response 1 (Egr1), which is up-regulated
during endothelin, angiotensin II, ischemia and stretch
treatments. Hairy/enhancer-of-split related with YRPW
motif 1 (Hey1), as well as its activator Notch1, were more
abundant in the ventricles than in the atria. Hey1 is
thought to repress ANF expression in the ventricles [15].
G protein signaling pathways generated by GenMapp Figure 5
G protein signaling pathways generated by GenMapp. Genes labeled in red indicate a higher expression level in the 
atria as compared to the ventricles based on a 1.8 fold threshold cut-off. Genes labeled in blue indicate a higher expression 
level in the ventricles as compared to the atria based on a -1.8 fold threshold cut-off. Genes labeled in white were not found in 
the list of statistically significant differentially expressed genes that was uploaded in GenMapp.BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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The known tissue specificity of several of these transcrip-
tion factors further illustrates the soundness of the dataset
and the identification of novel atrial abundant DNA bind-
ing proteins warrants further attention.
Of special importance to the understanding of the regula-
tion of hormone secretion by the atria are genes that
encode for molecular species involved in mechanical
aspect of atrial activity given that a major stimulus for ANF
and BNP secretion is atrial muscle stretch. This phenome-
non is referred to as "stretch-secretion coupling" [16].
Questions still remain regarding the exact stimulus per-
ceived by the atrial cardiocytes as well as the precise signal
transduction cascade that leads to an increase in ANF and
BNP secretion following stretch. Therefore, the finding
that mechanoreceptors (mechanically gated ion channels)
as well as mechanosensors (PLA2) are most abundant in
the atria is central to the generation and the testing of
hypothesis. Because some prostaglandins are known to be
potent stimulators of ANF synthesis and secretion [17], it
is of interest that the mechanosensor PLA2 is abundantly
expressed in the atria. Activation of PLA2 following
plasma membrane stretch could cause the release of ara-
chidonic acid, a substrate for prostaglandin synthase.
The rapid secretory response following stretch of atrial car-
diocytes as compared to the response to other ANF secre-
tion agonists such as endothelin-1 (ET-1) [18] has long
suggested that the phenomenon of stretch-secretion cou-
pling is related to mechanosensitive ion channels. It has
been suggested [19-22] that KATP channels are involved in
stretch-secretion coupling. These channels are stretch-sen-
sitive [23], are known to couple to G proteins, including
Gαo [24,25], and have been associated with other secre-
tory processes [26-28]. The results and conclusions
reached from investigations on the involvement of KATP
channels on ANF secretion have often been contradictory.
An inspection of the literature suggests that a likely reason
for these discrepancies may lie on differences in experi-
mental systems (in vivo or in vitro, perfused or non per-
fused tissues, etc.) [19-22]. Most importantly,
pharmacological studies have been made with little refer-
ence to the several candidate ion channels that may be
present in the atria. The present investigation shows that
Kir6.1 is significantly expressed in the ventricles. The ATP
binding cassette SUR2, whose expression level (1.79 fold)
didn't meet the fold cut-off criteria was more abundant in
the ventricles, and, while not significant, Kir6.2 and SUR1
had marginally higher expression in atria.
Three other channels had significantly higher levels of
expression in the atria over the ventricles. These included
the inward rectifiers Kcnj3, Kcnj5 and the background
channel TREK-1. Kcnj3,5 channels, which are activated by
G protein coupled receptors (GPCRs) coupled to pertussis
toxin (PTX) sensitive Gi/o proteins, exhibit mechanosensi-
tive properties and might participate in a mechanoelectri-
cal feedback pathway regulating ANF and BNP secretion
[29,30]. This view is in line with our recent finding that
PTX can abolish stretch secretion coupling [31]. The back-
ground channel TREK-1 produces an outwardly rectifying
current and is a member of the 2 pore domain potassium
(K2P) channel family. TREK-1 has been characterized as a
stretch-activated membrane channel. It is primarily
expressed in the central nervous system but has been
found in cardiac tissues [32] as well as in specific endo-
crine cells, such as adrenocortical cells [33]. Atrial abun-
dance of TREK-1 was further validated by RT-PCR (Figure
1). Immunohistochemical analysis localized TREK-1 pro-
tein in isolated adult rat atrial cardiocytes and it is sug-
gested that TREK-1 may act as a regulator of ANF secretion
[34].
The complex signal transduction pathways resulting from
the activation of GPCRs is in part orchestrated by an
assorted population of G proteins, assembled from a var-
ious combinations of 20 Gα, 5 Gβ and 12 Gγ isoforms [2].
Pathway analysis of the microarray data revealed differen-
tial expression of genes involved in G protein signaling
pathways between atrial and ventricular tissues. The G
protein Gαo isoform 1 was found more abundant in the
atria by both microarray and RT-PCR analyses and was
demonstrated by immunohistochemistry to co-localize
with ANF in atrial granules and in the sarcolemma [31].
Differential expression of the Gβ and Gγ subunit isoforms
was also observed between the atria and ventricles but the
functional significance of the differential G protein subu-
nit diversity is not well known.
The identification of accessory proteins involved in the
modulation of G protein signal transduction has helped
to gain insight into the mechanisms involved in the spe-
cificity of a cellular response from an assortment of exter-
nal stimuli. RGS proteins are capable of inhibiting
signaling by acting as a GTPase Accelerating/Activating
Protein (GAP), which accelerate the intrinsic rate of GTP
hydrolysis of the Gαi/o subunit [35]. The preponderance of
genes encoding for RGS proteins appears to be tissue spe-
cific. RGS2 and RGS6 were abundantly expressed in the
atria while RGS5 was found at higher levels in the ventri-
cles. These findings are confirmed by other studies in
which RGS mRNA and protein levels were measured
within atrial and ventricular cardiocytes [35-37].
In addition to the previously mentioned accessory pro-
teins, in this work we identified the atrial specific tran-
script Rasd1, also known as AGS1. AGS1 was found more
abundant in the atria by both microarray and RT-PCR
analyses. In the absence of receptor stimulation, AGS1, a
member of the Ras subgroup of small G proteins, specifi-BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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cally activates Gi/o heterotrimeric signaling pathways by
promoting nucleotide exchange on Gαi/o proteins and
enhancing Gβγ uncoupling from Gαi/o [38]. Since stretch
secretion coupling of ANF and BNP is mediated by PTX-
sensitive Gαi/o, the differential expression of AGS1, as well
as the other accessory proteins for G proteins identified in
this investigation, is of particular interest. Due to AGS1
opposing effects on Gi/o  mediated signaling following
agonist dependent or independent GPCR activation [39-
42], AGS1 may help orchestrate the complex diversity and
specificity of G protein signaling under different condi-
tions.
Conclusion
The data developed in this investigation describes for the
first time data on gene expression particularly centred on
the secretory function of the heart. Based on our data min-
ing strategy, we narrowed down the list of the 1415 differ-
entially expressed genes to a group of 115 genes.
Additional data filtering generated a subset of 20 candi-
date genes, described herein, that are likely involved in the
endocrine function of the heart. Of special interest is the
relationship between G proteins of the inhibitory type, as
well as their accessory proteins, and members of the
inward rectifiers and the two pore domain K+ channel
superfamily. This investigation provides the basis of
hypotheses formulation to further explore the endocrine
function of the heart in physiological and pathophysio-
logical conditions. Several lines of investigation are being
pursued in our laboratory based on the findings described
herein.
Methods
Total RNA extraction
The left atria appendage and the left ventricular free wall
were obtained from thirteen normal male Sprague Dawley
rats (225–275 g; Charles River Laboratories, Wilmington,
MA), sacrificed by decapitation. The experimental proto-
col was carried out according to the Canadian Council on
Animal Care Guide to the Care and use of Experimental
Animals following approval by the University of Ottawa
Animal Care Committee. The tissues were snap-frozen in
liquid nitrogen and stored at -80°C. Atrial and ventricular
tissues were grouped and then divided into 4 pools from
which total RNA was extracted using Trizol® (Invitrogen,
Carlsbad, CA) following the manufacturer's instructions.
Microarray hybridization
The quality of the extracted RNA from four independent
pools of atrial and ventricular tissue was assessed using an
Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA).
Ten μg of total RNA was used to generate the first strand
cDNA using the one cycle target labeling protocol. The
biotin-labeled cRNA was prepared according to the man-
ufacturer's protocol and hybridized to the GeneChip® Rat
Genome 230 2.0 Array (Affymetrix, Santa Clara, CA)
which contains 31042 probe sets and analyses over 30000
transcripts from 28000 genes. Detailed description of the
hybridization protocol is available at:
https://genomequebec.mcgill.ca/nanuqAdministration/
nanuq-administration/protocols.go. Four biological rep-
licates for each muscle type were generated. These steps
were carried out by the Genome Québec Innovation Cen-
tre (Montreal, QC).
Data analysis
The files that contain cell intensities (.CEL) were visually
inspected with the dChip http://www.dchip.org software
as a quality control measure in order to identify local
image contamination prior to normalization. Preliminary
expression summaries produced by Microarray Suite 5.0
(Affymetrix, Santa Clara, CA) (MAS5) software were used
to generate scatterplots, to assess microarray reproducibil-
ity, and detection calls. The normalized signal intensities
from the normal atrial replicates as well as from the nor-
mal ventricular replicates were visualized by pairwise scat-
terplots in which individual chips within the same group
were plotted against each other (within-class). The major-
ity of data points representing signal intensities for both
atrial and ventricular tissues were highly correlated for the
four replicates.
Further analysis was conducted using the expression level
summary files computed by Robust Multiple-Array Aver-
aging (RMA) which is implemented in Bioconductor
http://www.bioconductor.org. We used the RMA sum-
mary method, which generates background adjustments,
quantile normalizations and summarizations of the raw
scanned data in order to produce a measure of mRNA
expression levels. It has been shown that RMA has supe-
rior precision, better estimation of fold change and pro-
vides higher specificity and sensitivity when analyzing
fold changes to detect differentially expressed genes
[43,44]. Differential expression of genes was considered
to be significant based Significance Analysis of Microar-
rays (SAM) http://www-stat.stanford.edu/~tibs/SAM with
a False Discovery Rate (FDR) of 0.01%. Genes were con-
sidered biologically differentially expressed based on an
up- or down-regulation of expression levels by at least 1.8
fold (log base 2 = 0.848). The complete filtered raw data
can be found in Additional file 1. Sample hierarchical
clustering was performed with TIGR MeV software http://
www.tigr.org/software/tm4/index.html using the Pearson
uncentered correlation with complete linkage. Pathway
analysis, which identifies biologically relevant networks
that exist among differentially expressed genes, was done
by GenMAPP software http://www.genmapp.org. Func-
tional classification was carried out using GeneSpring 7.0
http://www.silicongenetics.com and Netaffx http://BMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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www.affymetrix.com software. The microarray data has
been deposited in the National Center for Biotechnology
Information's Gene Expression Omnibus (GEO) and
complies with MIAME standards (accession number:
GSE5266).
Real-time PCR
Real-time PCR was used to validate expression profiles of
transcripts using the Roche LightCycler 480 relative quan-
tification software. Standard curves were performed in
triplicate for each primer pair. G6PD was used as the ref-
erence gene. RT-PCR was performed in quadruplet for
each gene and the median crossing point was used to
determine the concentration ratio, based on the relative
standard curves for each target and reference gene. Most
primer nucleotide sequences were obtained from the liter-
ature and validated by PRIMER3 http://frodo.wi.mit.edu.
Primer sequences are listed in Table 4.
Immunohistochemistry
Paraffin-embedded, paraformaldehyde-fixed rat atrial tis-
sue sections were deparaffinized in toluene and hydrated
in a graded alcohol series. The sections were incubated for
30 minutes in 3% H2O2/methanol, washed for 5 minutes
in PBS, blocked with 5% normal goat serum in PBS for 60
min followed by a single wash in PBS and incubated with
the primary antibody in 2% normal goat serum, 2% BSA
in PBS overnight at 4°C, and then incubated for 60 min
with biotinylated anti-rabbit IgG. The primary antibody
dilution of secretogranin V antibody (SGNE1) (ab22699,
Abcam, Cambridge, MA) was 1:500. The slides were then
washed in PBS, incubated with Fluorescein Avidin D for
30 min, washed in PBS and distilled water and mounted
using Vectashield mounting media (Vectorlabs), and
examined with a Leica fluorescence confocal microscope.
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Additional material
Additional file 1
Filtered signal intensities data of atrial and ventricular biological rep-
licates. List of 1415 differentially expressed genes. Normalized signal 
intensities are shown for left atrial replicates (LA (n)) and left ventricular 
replicates (LV (n)). The average signal intensities of each probe set within 
the atrial and ventricular groups were calculated and the difference 
between the two averages was determined (log2 ratio).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-254-S1.xls]
Additional file 2
Differentially expressed genes between normal left atrial and left ven-
tricular tissues classified into the Ligand related functional groups. 
Positive fold change values indicate a higher abundance in the atria com-
pared to the ventricles, whereas negative fold change values demonstrate 
a higher ventricular abundance in comparison to the atria.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-254-S2.xls]
Table 4: Oligonucleotide sequences used for real-time PCR
Name Forward Primer Reverse Primer
ANF GCCGGTAGAAGATGAGGTCA GGGCTCCAATCCTGTCAATC
AGS1 GCGGCGAAGTCTACCAGTTG TGTCTAAGCTGAACACCAGAATGA
Bet1 AAGCAAGTGGGAGAGCAGAA GAGGAAAGAAACGGCCCTAC
BNP TCTGCTCCTGCTTTTCCTTA GAACTATGTGCCATCTTGGA
G6PD CCAGCCTTCTACAAGCACCTCAA AATAGCCCCCACAACCCTCAGTA
Gαo GTCACCGACATCATCATTGC AGGTTAGACAGGGGCTTGGT
Kcnj5 TCCTTCTAGTGCAGGCCATC TTTTCCAAGGTGAGGACTGG
Kir6.1 CACAAGAACATCCGAGAGCA CAGACTCCAGGCCACTCTTC
Nr2f2 AAAGTCCCAGTGTGCTTTGG ATATCCCGGATGAGGGTTTC
Pitx2 GTACCCCGGCTACTCGTACA CACCATGCTGGACGACATAC
RGS2 ATTGGAAGACCCGTTTGAGCTA TTCCTCAGGAGAAGGCTTGATAA
RGS6 ATGTCGGCGTTTGAAGAATC AAGCTTTCAGCCACTTTGGA
Sec22 GCAAGATGTGCAGAGGATCA ATCTCACAGCCACCAAAACC
SGNE1 TCCAAATCCCTGTCCTCTTG TGTCCAGCCTCTTTCCTTGT
TREK-1 GTGTCCTCTTCGTGGCTCTC ACGAGGATCCAGAACCACACBMC Genomics 2009, 10:254 http://www.biomedcentral.com/1471-2164/10/254
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